27.72MMarket Cap-1116P/E (TTM)
0.535High0.400Low564.14KVolume0.520Open0.511Pre Close248.76KTurnover1.45%Turnover RatioLossP/E (Static)64.49MShares4.24052wk High-0.43P/B16.74MFloat Cap0.31052wk Low--Dividend TTM38.95MShs Float10.940Historical High--Div YieldTTM26.40%Amplitude0.310Historical Low0.440Avg Price1Lot Size
Allurion Technologies Stock Forum
📊⚡️📊
Allurion Announces Submission of First Three Modules of Premarket Approval Application to the U.S. Food and Drug Administration for the Allurion Balloon
Allurion Announces Publication of Meta-Analysis Demonstrating the Safety and Effectiveness of the Allurion Program for Weight Loss
Allurion Technologies (NYSE: ALUR) has announced the publication of a meta-analysis demonstrating the safety and effectiveness of the Allurion Program for weight loss. The systematic review, which analyzed 11 studies involving 2,107 patients conducted between 2016 and 2024, reported an average weight reduction of 12.5% and a sign...
Lot to catch up and learn. 🫠
#weemorning #shareyourprofitloss
loading...
Allurion Receives Continued Listing Standards Notice from NYSE
Allurion Announces Publication of New Data Demonstrating Weight Loss in Adolescents Suffering from Obesity
Allurion Technologies (NYSE: ALUR) has published a study on the safety and effectiveness of the Allurion Program in adolescents with obesity. The study involved 91 adolescents aged 15-17 with an average BMI of 35.6. Key findings include:
- Average weight reduction of 13.1% four months after balloon placement
- No serious adverse events or early device re...
Allurion Announces Publication of New Data Demonstrating Continued Weight Loss at One Year On the Allurion Program
Allurion Technologies (NYSE: ALUR) has published a study showing impressive weight loss results with its Allurion Program. 486 patients achieved an average weight reduction of 10.5% at four months, improving to 13.7% at one year. The program combines the Allurion Balloon with virtual guidance and support, including monthly assessments using the A...
No comment yet